Mucke, J., Brinks, R., Fischer-Betz, R., Richter, J. G., Sander, O., Schneider, M., & Chehab, G. (2019). Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections. Patient Prefer Adherence.
Παραπομπή Chicago StyleMucke, Johanna, Ralph Brinks, Rebecca Fischer-Betz, Jutta G. Richter, Oliver Sander, Matthias Schneider, και Gamal Chehab. "Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections." Patient Prefer Adherence 2019.
Παραπομπή MLAMucke, Johanna, et al. "Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections." Patient Prefer Adherence 2019.